438 related articles for article (PubMed ID: 36273957)
1. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
[TBL] [Abstract][Full Text] [Related]
2. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
[TBL] [Abstract][Full Text] [Related]
3. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
[TBL] [Abstract][Full Text] [Related]
5. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.
Schramm R; Costard-Jäckle A; Rivinius R; Fischer B; Müller B; Boeken U; Haneya A; Provaznik Z; Knabbe C; Gummert J
Clin Res Cardiol; 2021 Aug; 110(8):1142-1149. PubMed ID: 34241676
[TBL] [Abstract][Full Text] [Related]
6. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.
Grupper A; Rabinowich L; Schwartz D; Schwartz IF; Ben-Yehoyada M; Shashar M; Katchman E; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
Am J Transplant; 2021 Aug; 21(8):2719-2726. PubMed ID: 33866672
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
Tunbridge M; Perkins GB; Singer J; Salehi T; Ying T; Grubor-Bauk B; Barry S; Sim B; Hissaria P; Chadban SJ; Coates PT
Trials; 2022 Sep; 23(1):780. PubMed ID: 36109788
[TBL] [Abstract][Full Text] [Related]
8. The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy.
Alshami A; Bahbah H; Al Attas R; Aldokhi F; Azzam A
Pediatr Transplant; 2024 May; 28(3):e14712. PubMed ID: 38553800
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients.
Simone S; Pesce F; Fontò G; Pronzo V; Pontrelli P; Conserva F; Schirinzi A; Casanova A; Gallo P; Rossini M; Lucarelli G; Spilotros M; Rendina M; Stallone G; Di Serio F; Di Leo A; Tafuri S; Ditonno P; Gesualdo L
J Nephrol; 2023 Jul; 36(6):1663-1671. PubMed ID: 37458909
[TBL] [Abstract][Full Text] [Related]
10. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
[TBL] [Abstract][Full Text] [Related]
11. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient.
Long J; Soni M; Muranski P; Miller MJ; Conry-Cantilena C; De Giorgi V
Front Immunol; 2023; 14():1207638. PubMed ID: 37465681
[TBL] [Abstract][Full Text] [Related]
13. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
14. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
[TBL] [Abstract][Full Text] [Related]
15. The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients.
Schmalz M; Vankova H; Rajnochova-Bloudickova S; Hruba P; Fialova M; Gurka J; Magicova M; Striz I; Zahradka I; Viklicky O
Int Urol Nephrol; 2023 Nov; 55(11):2959-2965. PubMed ID: 37027078
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
Matsunami M; Suzuki T; Sugihara S; Toishi T; Nagaoka K; Fukuda J; Ohara M; Takanashi Y; Ochi A; Yashima J; Kuji H; Matsue K
Transplant Proc; 2022; 54(6):1483-1488. PubMed ID: 35868872
[TBL] [Abstract][Full Text] [Related]
17. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial.
Drenko P; Kacer M; Kielberger L; Vlas T; Topolcan O; Kucera R; Reischig T
Transpl Infect Dis; 2023 Oct; 25(5):e14150. PubMed ID: 37724748
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
[TBL] [Abstract][Full Text] [Related]
20. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients.
Kermond RF; Ozimek-Kulik JE; Kim S; Alexander SI; Hahn D; Kesson A; Wood N; McCarthy HJ; Durkan AM
Pediatr Nephrol; 2023 Mar; 38(3):859-866. PubMed ID: 35833990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]